
Share on:
Orchid Orthopedic Solutions set out to redefine what additive manufacturing (AM) could deliver to orthopedic OEMs. The company focused its investment on titanium large joint implants, building a platform that could overcome cost and scalability limitations that are common across the market. In this webinar, revisit the assumptions that shaped that investment, the pivots Orchid made and the lessons learned from producing real devices through AM.
You’ll Learn:
- How supportless EBM printing reshaped cost, quality and post-processing efficiency and unlocked product design options. Supportless printing isn’t the future – it’s here.
- How today’s additive enables features and geometries (e.g., straight keels) that traditional manufacturing and older additive technologies couldn’t support at scale.
- What worked, what surprised Orchid, and what OEMs should know to take advantage of additive today.
Submit This Form to Watch Now*
*We respect your privacy. By completing this form, you are choosing to provide us with personal information which we will share with the sponsoring company. Under no circumstance will we lease, sell or share your information with any other person or entity.
RELATED ARTICLES
Sandvik to Divest Additive Manufacturing Business Unit
Jun 16 2026 , Julie A. Vetalice
Cretex Medical Acquires Select Assets and Capabilities of Holland Molds
Jun 16 2026 , Julie A. Vetalice
Medical Component Specialists Appoints President & CEO
Jun 15 2026 , Julie A. Vetalice



